RxDoctor Payments Data

Ravichandra Sandrapaty, MD

Radiation Oncology · Ocala, FLNPI 1467405209

Payments from drug & device makers

$110in general payments, 2019–2025

Across 5 payments — averaging $21.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teleflex LLC$50
  • Bayer$26
  • Novocure Inc.$21
  • Focal Therapeutics, Inc.$12

What the payments were for

  • Food & beverage$110100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Teleflex LLC2$50
Bayer1$26
Novocure Inc.1$21
Focal Therapeutics, Inc.1$12

How this compares

$110 in reported general payments places this provider in the 15th percentile of 465 radiation oncology providers in Florida.

See all radiation oncology providers in Florida

Medicare billing

Part B allowed, 2024
$756,508
Medicare patients
104
Services billed
3,791

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tamsulosin Hcl32$498

Paid to pharmacies, not to this prescriber.

Other radiation oncology in Ocala

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →